Rhythm Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
222 Berkeley St Fl 12, Boston, Massachus...Phone Number
(857) 264-4280Website
www.rhythmtx.comRevenue
$239.9 MillionStock Symbol
RYTMIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Rhythm Pharmaceuticals
Rhythm Pharmaceuticals is a global commercial-stage biopharmaceutical company dedicated to transforming the lives of people living with rare neuroendocrine diseases. The company focuses on developing and delivering precision medicines that address the underlying biological causes of complex and often underserved medical conditions. Through its research, development, and commercialization efforts, Rhythm Pharmaceuticals works to improve treatment options for patients who have historically faced limited therapeutic choices.Explore more
Rhythm Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
TS
Senior Director, Human Resources & Business P...
HT
Director, Human Resources, International (Jap...
TM
Director, Field Development
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rhythm Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Rhythm Pharmaceuticals
Click to see if Rhythm Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Rhythm Pharmaceuticals recently announced quarterly report
Check if Rhythm Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Rhythm Pharmaceuticals has new funding data
Product Launch: Get notified when Rhythm Pharmaceuticals launches new products
Check out if Rhythm Pharmaceuticals is spiking on competitors!
Rhythm Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Rhythm Pharmaceuticals
Find 2 more new buyers
Compare Similar Companies to Rhythm Pharmaceuticals
Compare insights from companies similar to Rhythm Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Rhythm Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Rhythm Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals financials insights
Gather financial insights about Rhythm Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Series A
$40M
2012
Series B
$33M
2017
Other Financing Round
$41M
Stock Offering
$138M
2018
Stock Offering
$174M
2019
Stock Offering
$172.5M
2022
Debt
$100M
2024
Series A
$150M
Rhythm Pharmaceuticals Tech Stack
A closer look at the technologies used by Rhythm Pharmaceuticals
Most Recent Scoops
Open Position
Open Position
Open Position
Person-Based
Earnings, Finance
Open Position
Rhythm Pharmaceuticals News & Media
Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can
Could this little-known biotech be a hidden gem?Rhythm (NASDAQ: RYTM) CTO sells 5079 shares in 10b5-1 plan - Stock Titan
CTO Joseph Shulman exercised 2,024 options at $6.80 and sold 5,079 shares at $119.75 on 2026-08-13 in a 10b5-1 plan, leaving 5,945 options.Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer
BOSTON, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced the appointment of Manher “AJ” Joshi, M.D., as Chief Medical Officer, effective August 17.Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment
-- MHRA grants authorization for patients 4 years of age and above with acquired hypothalamic obesity due to hypothalamic injury or impairment -- -- MHRA grants authorization for patients 4 years of age and above with acquired hypothalamic obesity due to hypothalamic injury or impairment --
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rhythm Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Rhythm Pharmaceuticals is a global commercial-stage biopharmaceutical company dedicated to transforming the lives of people living with rare neuroendocrine diseases. The company focuses on developing and delivering precision medicines that address the underlying biological causes of complex and often underserved medical conditions. Through its rese... Read More
